These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24508386)

  • 1. Effects of growth hormone administration for 6 months on bone turnover and bone marrow fat in obese premenopausal women.
    Bredella MA; Gerweck AV; Barber LA; Breggia A; Rosen CJ; Torriani M; Miller KK
    Bone; 2014 May; 62():29-35. PubMed ID: 24508386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial.
    Bredella MA; Lin E; Brick DJ; Gerweck AV; Harrington LM; Torriani M; Thomas BJ; Schoenfeld DA; Breggia A; Rosen CJ; Hemphill LC; Wu Z; Rifai N; Utz AL; Miller KK
    Eur J Endocrinol; 2012 Apr; 166(4):601-11. PubMed ID: 22275471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of growth hormone withdrawal in obese premenopausal women.
    Lin E; Bredella MA; Gerweck AV; Landa M; Schoenfeld D; Utz AL; Miller KK
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):914-9. PubMed ID: 23146135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral content and bone metabolism during physiological GH treatment in GH-deficient adults--an 18-month randomised, placebo-controlled, double blinded trial.
    Sneppen SB; Hoeck HC; Kollerup G; Sørensen OH; Laurberg P; Feldt-Rasmussen U
    Eur J Endocrinol; 2002 Feb; 146(2):187-95. PubMed ID: 11834427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of GH on body composition and cardiovascular risk markers in young men with abdominal obesity.
    Bredella MA; Gerweck AV; Lin E; Landa MG; Torriani M; Schoenfeld DA; Hemphill LC; Miller KK
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3864-72. PubMed ID: 23824419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women.
    Bredella MA; Torriani M; Ghomi RH; Thomas BJ; Brick DJ; Gerweck AV; Rosen CJ; Klibanski A; Miller KK
    Obesity (Silver Spring); 2011 Jan; 19(1):49-53. PubMed ID: 20467419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women.
    Ghiron LJ; Thompson JL; Holloway L; Hintz RL; Butterfield GE; Hoffman AR; Marcus R
    J Bone Miner Res; 1995 Dec; 10(12):1844-52. PubMed ID: 8619364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
    Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women.
    Tagliaferri M; Scacchi M; Pincelli AI; Berselli ME; Silvestri P; Montesano A; Ortolani S; Dubini A; Cavagnini F
    Int J Obes Relat Metab Disord; 1998 Sep; 22(9):836-41. PubMed ID: 9756240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-Term Effect of Estrogen on Human Bone Marrow Fat.
    Limonard EJ; Veldhuis-Vlug AG; van Dussen L; Runge JH; Tanck MW; Endert E; Heijboer AC; Fliers E; Hollak CE; Akkerman EM; Bisschop PH
    J Bone Miner Res; 2015 Nov; 30(11):2058-66. PubMed ID: 25982922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and body composition predictors of bone turnover and mineral content in obese postmenopausal women.
    Cherif R; Mahjoub F; Sahli H; Cheour E; Sakly M; Attia N
    Clin Rheumatol; 2019 Mar; 38(3):739-747. PubMed ID: 30341704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of zoledronic acid on vertebral marrow adiposity in postmenopausal osteoporosis assessed by MR spectroscopy.
    Yang Y; Luo X; Yan F; Jiang Z; Li Y; Fang C; Shen J
    Skeletal Radiol; 2015 Oct; 44(10):1499-505. PubMed ID: 26130070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women.
    Holloway L; Butterfield G; Hintz RL; Gesundheit N; Marcus R
    J Clin Endocrinol Metab; 1994 Aug; 79(2):470-9. PubMed ID: 7519191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of bone mineral density in obese premenopausal women.
    Bredella MA; Torriani M; Ghomi RH; Thomas BJ; Brick DJ; Gerweck AV; Harrington LM; Breggia A; Rosen CJ; Miller KK
    Bone; 2011 Apr; 48(4):748-54. PubMed ID: 21195217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.
    Kim KR; Nam SY; Song YD; Lim SK; Lee HC; Huh KB
    Horm Res; 1999; 51(2):78-84. PubMed ID: 10352397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of growth hormone on body composition and visceral adiposity in middle-aged men with visceral obesity.
    Pasarica M; Zachwieja JJ; Dejonge L; Redman S; Smith SR
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4265-70. PubMed ID: 17785361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone is positively associated with surrogate markers of bone turnover during puberty.
    Russell M; Breggia A; Mendes N; Klibanski A; Misra M
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):482-8. PubMed ID: 21535073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teriparatide for idiopathic osteoporosis in premenopausal women: a pilot study.
    Cohen A; Stein EM; Recker RR; Lappe JM; Dempster DW; Zhou H; Cremers S; McMahon DJ; Nickolas TL; Müller R; Zwahlen A; Young P; Stubby J; Shane E
    J Clin Endocrinol Metab; 2013 May; 98(5):1971-81. PubMed ID: 23543660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women.
    Adami S; Zivelonghi A; Braga V; Fracassi E; Gatti D; Rossini M; Ulivieri FM; Viapiana O
    Bone; 2010 Jan; 46(1):244-7. PubMed ID: 19853071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Bone Turnover Markers Are Associated With Distal Radius Fractures in Premenopausal Women.
    Ting BL; Walley KC; Travison TG; Rozental TD
    J Hand Surg Am; 2017 Feb; 42(2):71-77. PubMed ID: 28160903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.